PSORS11
MCID: PSR032
MIFTS: 43

Psoriasis 11 (PSORS11)

Categories: Genetic diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Psoriasis 11

MalaCards integrated aliases for Psoriasis 11:

Name: Psoriasis 11 58 76
Psoriasis 11, Susceptibility to 58 30
Psoriasis Susceptibility 11 58 13
Psoriasis Vulgaris 76 74
Psoriasis 76 74
Psors11 58 76
Pv 76

Classifications:



External Ids:

OMIM 58 612599
MeSH 45 D011565
MedGen 43 C2675475

Summaries for Psoriasis 11

UniProtKB/Swiss-Prot : 76 Psoriasis 11: A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis.

MalaCards based summary : Psoriasis 11, also known as psoriasis 11, susceptibility to, is related to guttate psoriasis and pustular psoriasis, and has symptoms including pruritus, exanthema and psoriasiform rash. An important gene associated with Psoriasis 11 is PSORS11 (Psoriasis Susceptibility 11). Affiliated tissues include skin, t cells and thyroid.

Description from OMIM: 612599

Related Diseases for Psoriasis 11

Diseases in the Psoriasis family:

Psoriasis 1 Psoriasis 3
Psoriasis 2 Psoriasis 4
Psoriasis 5 Psoriasis 6
Psoriasis 7 Psoriasis 9
Psoriasis 8 Psoriasis 10
Psoriasis 11 Psoriasis 12
Psoriasis 13

Diseases related to Psoriasis 11 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 768)
# Related Disease Score Top Affiliating Genes
1 guttate psoriasis 12.6
2 pustular psoriasis 12.6
3 psoriasis 15, pustular 12.5
4 polycythemia vera 12.5
5 psoriatic arthritis 12.4
6 psoriasis 10 12.2
7 psoriasis 6 12.2
8 psoriasis 3 12.2
9 psoriasis 9 12.2
10 pustulosis palmaris et plantaris 12.2
11 psoriasis 4 12.1
12 psoriasis 5 12.1
13 psoriasis 8 12.1
14 psoriasis 12 12.1
15 pustulosis of palm and sole 12.1
16 mental retardation and psoriasis 12.1
17 psoriatic juvenile idiopathic arthritis 12.0
18 tranebjaerg svejgaard syndrome 11.8
19 psoriasis 1 11.8
20 impetigo herpetiformis 11.7
21 arthritis 11.6
22 geographic tongue 11.5
23 parapsoriasis 11.5
24 pemphigus vulgaris, familial 11.4
25 persistent vegetative state 11.4
26 pulmonary valve stenosis 11.4
27 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.3
28 chronic recurrent multifocal osteomyelitis 11.3
29 subacute cutaneous lupus erythematosus 11.3
30 psoriasis 11.3
31 psoriasis 14, pustular 11.2
32 singleton-merten syndrome 1 11.1
33 systemic onset juvenile idiopathic arthritis 11.1
34 porphyria variegata 11.1
35 psoriasis 2 11.1
36 psoriasis 7 11.1
37 psoriasis 13 11.1
38 nail disorder, nonsyndromic congenital, 1 11.0
39 singleton-merten syndrome 2 11.0
40 temporomandibular ankylosis 11.0
41 primary cutaneous amyloidosis 11.0
42 combined immunodeficiency with skin granulomas 11.0
43 singleton-merten syndrome 11.0
44 dermatitis 10.8
45 dermatitis, atopic 10.6
46 rheumatoid arthritis 10.5
47 vitiligo-associated multiple autoimmune disease susceptibility 1 10.4
48 polycythemia 10.4
49 hepatitis 10.4
50 alopecia 10.4

Graphical network of the top 20 diseases related to Psoriasis 11:



Diseases related to Psoriasis 11

Symptoms & Phenotypes for Psoriasis 11

Clinical features from OMIM:

612599

UMLS symptoms related to Psoriasis 11:


pruritus, exanthema, psoriasiform rash

Genetic Tests for Psoriasis 11

Genetic tests related to Psoriasis 11:

# Genetic test Affiliating Genes
1 Psoriasis 11, Susceptibility to 30

Anatomical Context for Psoriasis 11

MalaCards organs/tissues related to Psoriasis 11:

42
Skin, T Cells, Thyroid, Bone, Heart, Tongue, Prostate

Publications for Psoriasis 11

Articles related to Psoriasis 11:

(show top 50) (show all 1006)
# Title Authors Year
1
Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris. ( 31097934 )
2019
2
A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris. ( 30293440 )
2019
3
Analyses of association of psoriatic arthritis and psoriasis vulgaris with functional NCF1 variants. ( 30753645 )
2019
4
Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment. ( 30530442 )
2019
5
Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence. ( 30474868 )
2019
6
Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy. ( 30323005 )
2019
7
Case of psoriasis vulgaris with atrial fibrillation, heart failure and chronic kidney disease which were found accidentally through blood examination during apremilast treatment. ( 30663127 )
2019
8
Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. ( 30628103 )
2019
9
Correlation between Serum Brain-Derived Neurotrophic Factor Level and Depression Severity in Psoriasis Vulgaris Patients. ( 30894916 )
2019
10
Co-existence of Juvenile dermatomyositis and psoriasis vulgaris with fungal infection: A case report and literature review. ( 30697901 )
2019
11
Evaluation of Toll-like receptor expression profile in patients with psoriasis vulgaris. ( 30935923 )
2019
12
Efficacy of biologic therapies in psoriasis vulgaris. ( 30983095 )
2019
13
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris. ( 30859087 )
2019
14
Topische Therapie bei Psoriasis vulgaris - ein Behandlungspfad. ( 30883011 )
2019
15
Patient experiences of using Chinese herbal medicine for psoriasis vulgaris and chronic urticaria: A qualitative study. ( 30897010 )
2019
16
Association Study of the Caspase Gene Family and Psoriasis Vulgaris Susceptibility in Northeastern China. ( 30906769 )
2019
17
Correlations between related-purine derivatives and renal disorders in patients with psoriasis vulgaris. ( 30679967 )
2019
18
The analysis of the therapeutic potential of ustekinumab in psoriasis vulgaris treatment. ( 30693647 )
2019
19
Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept. ( 30703387 )
2019
20
Association analysis of the major histocompatibility complex region in psoriasis vulgaris. ( 30737775 )
2019
21
PLA2R antibody positive membranous glomerulonephropathy associated with psoriasis vulgaris. ( 30757997 )
2019
22
Serum adropin levels in psoriasis vulgaris and its relation with metabolic parameters ( 30762319 )
2019
23
Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris. ( 30778377 )
2019
24
Thuvaraka rasayana regimen in Psoriasis vulgaris - A case report. ( 30606464 )
2019
25
Relapsing Polychondritis Associated With Psoriasis Vulgaris. ( 30614891 )
2019
26
A Cost-utility Analysis of Calcipotriol/betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden. ( 30628631 )
2019
27
Expression of B and T lymphocyte attenuator, retinoid-related orphan receptor gamma-isoform-t and interleukin 7 in psoriasis vulgaris. ( 30671936 )
2019
28
Clinical and molecular evaluation of therapy with the use of cyclosporine A in patients with psoriasis vulgaris. ( 30350412 )
2019
29
Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population. ( 30387497 )
2019
30
Effect of low-dose acitretin treatment on pituitary hormones in psoriasis vulgaris: A retrospective study. ( 29855455 )
2019
31
Adult-onset Still's disease in a patient with psoriasis vulgaris showing inverse correlation of disease activity. ( 29083047 )
2018
32
Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris. ( 30687070 )
2018
33
De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation. ( 30410803 )
2018
34
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast. ( 30536461 )
2018
35
Pemphigus Associated with Psoriasis Vulgaris: A Retrospective Study of Seven Patients and a Review of the Literature. ( 30390724 )
2018
36
Psoriasis vulgaris in a patient with pemphigus vulgaris on corticosteroid therapy. ( 29689136 )
2018
37
Auftreten einer Psoriasis vulgaris bei einem Patienten mit Pemphigus vulgaris unter Kortikosteroidtherapie. ( 29750447 )
2018
38
Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris. ( 30430554 )
2018
39
Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris. ( 30582717 )
2018
40
Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy. ( 30482111 )
2018
41
Genetic polymorphism predicting Methotrexate efficacy in Chinese patients with psoriasis vulgaris. ( 30563733 )
2018
42
Association of ERAP1 gene polymorphisms with the susceptibility to psoriasis vulgaris: A case-control study. ( 30313118 )
2018
43
Expression of death receptor 3 (DR3) on peripheral blood mononuclear cells of patients with psoriasis vulgaris. ( 30341229 )
2018
44
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature. ( 30349342 )
2018
45
Serum Levels of Aryl Hydrocarbon Receptor, Cytochromes P450 1A1 and 1B1 in Patients with Exacerbated Psoriasis Vulgaris. ( 30394267 )
2018
46
Hochregulation der SLURP1-Immunfärbung in Läsionen von Psoriasis-vulgaris-Patienten entspricht dem Schweregrad der Erkrankung. ( 30395397 )
2018
47
Lesional upregulation of SLURP1 immunostaining parallels disease severity in psoriasis vulgaris patients. ( 30395407 )
2018
48
Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review. ( 30186132 )
2018
49
Mean platelet volume and platelet distribution width levels in patients with mild psoriasis vulgaris with metabolic syndrome. ( 30206448 )
2018
50
Treatment of psoriasis vulgaris using low-dose naltrexone. ( 30238048 )
2018

Variations for Psoriasis 11

Expression for Psoriasis 11

Search GEO for disease gene expression data for Psoriasis 11.

Pathways for Psoriasis 11

GO Terms for Psoriasis 11

Sources for Psoriasis 11

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....